SRPT - Company ID 0000873303
Sarepta Therapeutics, Inc. (SRPT) reported revenue of $2.20B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $2.20B | +15.6% |
| FY 2024 | $1.90B | +53.0% |
| FY 2023 | $1.24B | +33.3% |
| FY 2022 | $933.01M | +32.9% |
| FY 2021 | $701.89M | +30.0% |
| FY 2020 | $540.10M | +41.8% |
| FY 2019 | $380.83M | +26.5% |
| FY 2018 | $301.03M | +94.7% |
| FY 2017 |
Sarepta Therapeutics, Inc. (SRPT) reported revenue of $2.20B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2014 and fiscal 2025, Sarepta Therapeutics, Inc.'s revenue grew from $9.76M to $2.20B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $154.58M |
| +2751.6% |
| FY 2016 | $5.42M | +332.6% |
| FY 2015 | $1.25M | -87.2% |
| FY 2014 | $9.76M | - |